Group 135

Join us to save lives


Our mission

We assist cancer patients in receiving the optimal treatment medicine can offer. we leverage AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from the biopsy image alone. By doing so, we overcome economical, logistical, and technological barriers to reach the full potential of personalized medicine for cancer patients.

Through global collaborations with top-tier medical centers and pharmaceutical companies, Imagene AI is revolutionizing molecular screening for both clinical practice and research.

Our success derives from our cutting-edge technology and talented multidisciplinary team of biologists, doctors, data scientists, software engineers, and business experts.

This is the perfect time to join us!

  • Our solutions are already in the market, after successful validation tests that were done by top-tier medical centers and on various cancer types.
  • We are expanding globally with more sites in North America, Europe and Israel.
  • We are a diverse startup with bright, passionate and most of all fun team from multidisciplinary fields.
  • Every member of our team has a meaningful impact on the lives of cancer patients.
  • We are an emerging leader in the realm of precision medicine.

Our foundations

Imagene was established in 2020, by people who shared the same passion – to fulfill the potential of deep learning technology to simplify the process of matching the most effective treatment for each cancer patient.